191 related articles for article (PubMed ID: 30993931)
1. Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
Liu C; Xi Y; Li M; Jiao Q; Zhang H; Yang Q; Yao W
Korean J Radiol; 2019 May; 20(5):801-811. PubMed ID: 30993931
[TBL] [Abstract][Full Text] [Related]
2. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy.
Fu J; Tang L; Li ZY; Li XT; Zhu HF; Sun YS; Ji JF
Eur J Radiol; 2020 Jul; 128():108974. PubMed ID: 32416553
[TBL] [Abstract][Full Text] [Related]
3. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
4. The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging.
Hu F; Tang W; Sun Y; Wan D; Cai S; Zhang Z; Grimm R; Yan X; Fu C; Tong T; Peng W
Oncotarget; 2017 Sep; 8(43):75597-75606. PubMed ID: 29088894
[TBL] [Abstract][Full Text] [Related]
5. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T.
Lee SK; Jee WH; Jung CK; Im SA; Chung NG; Chung YG
PLoS One; 2020; 15(3):e0229983. PubMed ID: 32155203
[TBL] [Abstract][Full Text] [Related]
7. Diffusion kurtosis imaging assessment of the response to radiotherapy in a VX2 bone tumor model: an animal study.
Guo J; Dong C; Wu Z; Sun W; Li X; Zhou R; Xu W
Acta Radiol; 2022 Feb; 63(2):182-191. PubMed ID: 33535770
[TBL] [Abstract][Full Text] [Related]
8. [Application of apparent diffusion coefficient combined with serum tumor markers detection in evaluating neoadjuvant chemotherapy for osteosarcoma].
Wang Z; Liu L; Song YX; Zhang H; She W; Qian YW
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1012-1016. PubMed ID: 32294859
[No Abstract] [Full Text] [Related]
9. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
[TBL] [Abstract][Full Text] [Related]
10. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
11. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.
Oka K; Yakushiji T; Sato H; Hirai T; Yamashita Y; Mizuta H
Skeletal Radiol; 2010 Feb; 39(2):141-6. PubMed ID: 19924412
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
13. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
[TBL] [Abstract][Full Text] [Related]
14. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer.
Zhang Z; Zhang Y; Hu F; Xie T; Liu W; Xiang H; Li X; Chen L; Zhou Z
Cancer Imaging; 2024 Feb; 24(1):29. PubMed ID: 38409049
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Diffusion-Weighted Imaging in Neoadjuvant Chemotherapy for Osteosarcoma: A Systematic Review and Meta-Analysis.
Yuan W; Yu Q; Wang Z; Huang J; Wang J; Long L
Acad Radiol; 2022 Feb; 29(2):326-334. PubMed ID: 33386220
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.
Habre C; Dabadie A; Loundou AD; Banos JB; Desvignes C; Pico H; Aschero A; Colavolpe N; Seiler C; Bouvier C; Peltier E; Gentet JC; Baunin C; Auquier P; Petit P
Pediatr Radiol; 2021 Aug; 51(9):1714-1723. PubMed ID: 33877417
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
18. SLIC-supervoxels-based response evaluation of osteosarcoma treated with neoadjuvant chemotherapy using multi-parametric MR imaging.
Baidya Kayal E; Kandasamy D; Sharma R; Sharma MC; Bakhshi S; Mehndiratta A
Eur Radiol; 2020 Jun; 30(6):3125-3136. PubMed ID: 32086578
[TBL] [Abstract][Full Text] [Related]
19. Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
Xu Q; Xu Y; Sun H; Chan Q; Shi K; Song A; Wang W
J Magn Reson Imaging; 2018 Jul; 48(1):248-258. PubMed ID: 29281151
[TBL] [Abstract][Full Text] [Related]
20. Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients.
Chen Y; Ren W; Zheng D; Zhong J; Liu X; Yue Q; Liu M; Xiao Y; Chen W; Chan Q; Pan J
J Magn Reson Imaging; 2015 Nov; 42(5):1354-61. PubMed ID: 25873208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
